>> 全站文章索引 >> 第23页:
  • Patient beliefs predict response to paroxetine among primary care patients with dysthymia and minor depression - [Department of Psychiatry, University of Washington, Seattle 98195, USA.]
  • Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial - [Michael J. Detke, Curtis G. Wiltse, Craig H. Mallinckrodt, Robert K. McNamara, Mark A. Demitrack and Istvan Bitter]
  • Quality of life after treatment for incidental, unruptured intracranial aneurysms - [Solheim O, Eloqayli H, Muller TB, Unsgaard G.]
  • Stepped collaborative care for primary care patients with persistent symptoms of depression: A randomized trial - [Dr. W. Katon, Department of Psychiatry, Univ. of Washington School of Med., Box 35-6560, Seattle, WA 98195; United States. E-Mail: wkaton@u.washington.edu.]
  • Auditory Evoked Potentials Reflect Serotonergic Neuronal Activity?A Study in Behaving Cats Administered Drugs Acting on 5-HT1A Autoreceptors in the Dorsal Raphe Nucleus - [Georg Juckel1 MD, Ulrich Hegerl1 MD, Ph.D, Márk Molnár2 MD, Ph.D, Valéria Csépe2 Ph.D and George Karmos2 MD, Ph.D]
  • How psychotherapy changes the brain – the contribution of functional neuroimaging - [D E J Linden1,2]
  • Does blinding of readers affect the results of meta-analyses? - [Jesse A Berlin]
  • Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression - [Zanardi, Raffaella, Franchini, Linda, Gasperini, Mariangela, Perez, Jorge, Smeraldi, Enrico]
  • Drug Metabolism Reviews 301-400 - [.]
  • Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period - [Brian J. Piper and Jerrold S. Meyer]
  • Short- and long-term effects of MDMA (“ecstasy”) on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo - [Inger Lise Bogen, Kristin Huse Haug, Oddvar Myhre and Frode Fonnum]
  • Characterization of the Translocation of Protein Kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/Ecstasy) in Synaptosomes: Evidence for a Presynaptic Localization Involving the Serotonin Transporter (SERT) - [H Kenneth Kramer1 MD, Ph.D, Jose C Poblete2 Ph.D and Efrain C Azmitia2 Ph.D]
  • Effect of Subchronic Antidepressant Treatments on Behavioral, Neurochemical, and Endocrine Changes in the Forced-Swim Test - [Thomas J. Connor, Padraig Kelliher, Yan Shen, Andrew Harkin, John P. Kelly and Brian E. Leonard]
  • 2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand - [Shunichi Oya, Seok-Rye Choi, Catherine Hou, Mu Mu, Mei-Ping Kung, Paul D. Acton, Michael Siciliano and Hank F. Kung]
  • Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia - [.]
  • Antimicrobial activity of psychotropic drugs: Selective serotonin reuptake inhibitors - [J. L. Munoz-Bellido, S. Munoz-Criado and J. A. Garcìa-Rodrìguez]
  • Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis - [Isabelle Malagié, Antoine Deslandes and Alain M. Gardier]
  • Modification of presynaptic CaM kinase II affinity for ATP in hippocampus after long term blockade of serotonin reuptake - [Elena Consogno, Cinzia Dorigo, Giorgio Racagni and Maurizio Popoli]
  • Will a second prophylactic treatment with a higher dosage of the same antidepressant either prevent or delay new depressive episodes? - [Linda Franchini, David Rossini, Fanny Bongiorno, Chiara Spagnolo, Enrico Smeraldi and Raffaella Zanardi]
  • Ontogeny of drug-metabolizing enzymes and its influence on the pathogenesis of adverse drug reactions in children - [J. Steven Leeder]
  • Reduction in serotonin synthesis following acute and chronic treatments with paroxetine, a selective serotonin reuptake inhibitor, in rat brain: an autoradiographic study with α-[14C]methyl--tryptophan - [Fumitaka Yamane, Hidehiko Okazawa, Pierre Blier and Mirko Diksic]
  • Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons - [Steven T. Szabo and Pierre Blier]
  • Effect of SB-243213, a selective 5-HT2C receptor antagonist, on the rat sleep profile: A comparison to paroxetine - [M. I. Smith, D. C. Piper, M. S. Duxon and N. Upton]
  • A Pilot Trial of Paroxetine for the Treatment of Hot Flashes and Associated Symptoms in Women with Breast Cancer - [Michael A. Weitzner, Joanne Moncello, Paul B. Jacobsen and Susan Minton]
  • Intent-to-treat analysis for clinical trials: use of data collected after termination of treatment protocol - [Sati Mazumdar, Patricia R. Houck, Kenneth S. Liu, Benoit H. Mulsant, Bruce G. Pol1ock, Mary Amanda Dew and Charles F. Reynolds III]
  • Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling - [J. Landgrebe, G. Welzl, T. Metz, M. M. van Gaalen, H. Ropers, W. Wurst and F. Holsboer]
  • EEG correlates of acute and chronic paroxetine treatment in depression - [Verner Knott, Colleen Mahoney, Sidney Kennedy and Kenneth Evans]
  • Course and rate of antidepressant response in the very old - [Ariel G. Gildengers, Patricia R. Houck, Benoit H. Mulsant, Bruce G. Pollock, Sati Mazumdar, Mark D. Miller, Mary Amanda Dew, Ellen Frank, David J. Kupfer and Charles F. Reynolds III]
  • How well do antidepressants work in older people? A systematic review of Number Needed to Treat - [.]
  • Effect of treatment of panic disorder in patients with frequent ICD discharges: a pilot study - [P. M. J. C. Kuijpers, A. Honig and H. J. J. Wellens]
  • Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT1B receptor knock-out mice - [Isabelle Malagié, Denis J. David, Pascale Jolliet, René Hen, Michel Bourin and Alain M. Gardier]
  • Differential effects of chronic antidepressant treatments on μ- and δ-opioid receptors in rat brain - [Catherine Vilpoux, Céline Carpentier, Isabelle Leroux-Nicollet, Laurent Naudon and Jean Costentin]
  • Penetrating the blind in a study of an SSRI - [Melissa P. Piasecki, David O. Antonuccio, Gerri M. Steinagel, Barbara S. Kohlenberg and Karen Kapadar]
  • Serotonin, 5-hydroxyindoleacetic acid and serotonin transporter in blood peripheral lymphocytes of patients with generalized anxiety disorder - [E. Hernández, S. Lastra, M. Urbina, I. Carreira and L. Lima]
  • Acute effects of amperozide and paroxetine on social cohesion in male conspecifics - [David J. Rademacher, Anthony P. Anderson and Rhea E. Steinpreis]
  • Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography - [L. Labat, M. Deveaux, P. Dallet and J. P. Dubost]
  • Reduced (±)-3,4-methylenedioxymethamphetamine (“Ecstasy”) metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro - [Yamini Ramamoorthy, Ai-ming Yu, Nina Suh, Robert L. Haining, Rachel F. Tyndale and Edward M. Sellers]
  • Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative - [Feng C. Zhou, Klaus-Peter Lesch and Dennis L. Murphy]
  • Aging alters in a region-specific manner serotonin transporter sites and 5-HT1A receptor-G protein interactions in hamster brain - [Marilyn J. Duncan and Julie G. Hensler]
  • Predicting treatment-outcome in cocaine dependence from admission urine drug screen and peripheral serotonergic measures - [Ashwin A. Patkar, Charles C. Thornton, Wade H. Berrettini, Edward Gottheil, Stephen P. Weinstein and Kevin P. Hill]
  • Clinical implications of pharmacogenetics of antidepressants - [Koichi Otani, Kazuo Mihara, Norio Yasui-Furukori, Akihito Suzuki, Tsuyoshi Kondo and Sunao Kaneko]
  • A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression - [S. Kasper and J. P. Olié]
  • Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study - [Eric Michael Kaplan]
  • 7,7,8,8-Tetracyanoquinodimethane as a new derivatization reagent for high-performance liquid chromatography and thin-layer chromatography: rapid screening of plasma for some antidepressants - [Aysel Oztunc, Armagan Onal and S?d?ka Erturk]
  • Carnosine prevents methamphetamine-induced gliosis but not dopamine terminal loss in rats - [David Pubill, Ester Verdaguer, Francesc X. Sureda, Antoni Camins, Mercè Pallàs, Jordi Camarasa and Elena Escubedo]
  • A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder - [Paola Rocca, Valeria Fonzo, Luigi Ravizza, Giuseppe Rocca, Monica Scotta, Enrico Zanalda and Filippo Bogetto]
  • Different distributions of the 5-HT reuptake complex and the postsynaptic 5-HT2A receptors in Brodmann areas and brain hemispheres - [Pilar Rosel, Belén Arranz, Mikel Urretavizcaya, Miguel Oros, Luis San, Julio Vallejo and Miguel Angel Navarro]
  • An open-label dosing study of paroxetine in depressed children and adolescents - [Robert L. Findling, Carolyn Myers, Mary Ann O]
  • Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures - [Vikram K. Yeragani, Vanessa Pesce, Anusha Jayaraman and Steven Roose]
  • Inhibition of vesicular uptake of monoamines by hyperforin - [Netta Roz, Yehuda Mazur, Amiram Hirshfeld and Moshe Rehavi]
  • Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression - [Paola Rocca, Concetta De Leo, Carola Eva, Livio Marchiaro, Anna Maria Milani, Rita Musso, Luigi Ravizza, Enrico Zanalda and Filippo Bogetto]
  • Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine - [D. Gervasoni, E. Panconi, V. Henninot, R. Boissard, B. Barbagli, P. Fort and P. H. Luppi]
  • A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes - [Paola Rocca, Livio Marchiaro, Roberta Rasetti, Elisa Rivoira and Filippo Bogetto]
  • Morphine, cocaine and antidepressant induced motivational activity and midbrain dopaminergic neurotransmission - [Paul N Deslandes, David M Pache, Paul Buckland and Robert D.E Sewell]
  • Enzymatic resolution of (±)-trans-4-(4′-fluorophenyl)-6-oxo-piperidin-3-ethyl carboxylate, an intermediate in the synthesis of (?)-Paroxetine - [Jose M. Palomo, Gloria Fernández-Lorente, Cesar Mateo, Roberto Fernández-Lafuente and José M. Guisan]
  • A retrospective analysis of the revocation of prior authorization restrictions and the use of antidepressant medications for treating major depressive disorder - [Jeffrey S. McCombs, Lizheng Shi, Glen L. Stimmel and Thomas W. Croghan]
  • Improved sample preparation for the quantitative analysis of paroxetine in human plasma by stable isotope dilution negative ion chemical ionisation gas chromatography–mass spectrometry - [Hans J?rg Leis, Werner Windischhofer and Günter Fauler]
  • Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramine - [Jun Fujishiro, Taiichiro Imanishi, Kaname Onozawa and Masaki Tsushima]
  • High-performance liquid chromatography–mass spectrometry method for the determination of paroxetine in human plasma - [Zhimeng Zhu and Len Neirinck]
  • The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression - [Dorotea Mück-eler, Nela Pivac, Marina agud, Miro Jakovljevi and Alma Mihaljevi-Pele]
  • Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus - [Rebeca Martinez-Turrillas, Diana Frechilla and Joaquín Del Río]
  • Enzymatic production of (3S,4R)-(?)-4-(4′-fluorophenyl)-6-oxo-piperidin-3-carboxylic acid using a commercial preparation from Candida antarctica A: the role of a contaminant esterase - [Jose M. Palomo, Gloria Fernández-Lorente, Cesar Mateo, Manuel Fuentes, Jose M. Guisan and Roberto Fernández-Lafuente]
  • Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation - [Juza Chen, Nicola J. Mabjeesh, Haim Matzkin and Alexander Greenstein]
  • Influence of antidepressants on intracellular levels of cyclic adenosine monophosphate in human peripheral blood mononuclear cells - [Gunter Kenis, Harry Steinbusch, Marc De Baets and Michael Maes]
  • Cerebral blood volume and clinical changes on the third day of placebo substitution for SSRI treatment - [Michael E. Henry, Marc J. Kaufman, John Hennen, David Michelson, Mark E. Schmidt, Eve Stoddard, Alexander J. Vukovic, Paul J. Barreira, Bruce M. Cohen and Perry F. Renshaw]
  • Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity - [Gregers Wegener, Vallo Volke, Brian H. Harvey and Raben Rosenberg]
  • Fox odour affects corticosterone release but not hippocampal serotonin reuptake and open field behaviour in rats - [Danusa Dias Soares, Francesca Fernandez, Sylvie Aguerre, Aline Foury, Pierre Mormède and Francis Chaouloff]
  • Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review - [Meera Vaswani, Farzana Kadar Linda and Subramanyam Ramesh]
  • Strain-dependent modification of behavior following antidepressant treatment - [Shanaz Tejani-Butt, Joseph Kluczynski and William P. Paré]
  • Effects of Hypericum perforatum and paroxetine in the mouse defense test battery - [Vanessa Beijamini and Roberto Andreatini]
  • Chronic paroxetine infusion influences macronutrient selection in male Sprague–Dawley rats - [A. T. M. Konkle, K. B. Sreter, S. L. Baker and C. Bielajew]
  • Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats - [V. Sanchez, J. Camarero, E. O’Shea, A. R. Green and M. I. Colado]
  • Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT2C receptor responsivity - [E. J. Bull, P. H. Hutson and K. C. F. Fone]
  • Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine - [Robert D. Nebes, Bruce G. Pollock, Patricia R. Houck, Meryl A. Butters, Benoit H. Mulsant, Michelle D. Zmuda and Charles F. Reynolds]
  • Mirtazapine for Pruritus - [Mellar P. Davis, Jan L. Frandsen, Declan Walsh, Steven Andresen and Sandy Taylor]
  • Platelet counts in depressed patients treated with amitriptyline or paroxetine - [F. Lederbogen, E. H?rer, R. Hellweg, I. Heuser and M. Deuschle]
  • Serotonin transporter gene polymorphisms and platelet [3H] paroxetine binding in premenstrual dysphoria - [J. Melke, L. Westberg, M. Landén, C. Sundblad, O. Eriksson, F. Baghei, R. Rosmond, E. Eriksson and A. Ekman]
  • Serotonergic activity measured by platelet [3H]paroxetine binding in patients with eating disorders - [Carla E. Ramacciotti, Elisabetta Coli, Riccardo Paoli, Donatella Marazziti and Liliana Dell]
  • Tail-suspension induced hyperthermia: a new measure of stress reactivity - [Xiaoqing Liu, Dorothy Peprah and Howard K. Gershenfeld]
  • Neurosteroid secretion in panic disorder - [Francesca Brambilla, Giovanni Biggio, Maria Giuseppina Pisu, Laura Bellodi, Giampaolo Perna, Vesna Bogdanovich-Djukic, Robert H. Purdy and Mariangela Serra]
  • Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder - [Giuseppina D]
  • Bi-phasic change in BDNF gene expression following antidepressant drug treatment - [A. L. Coppell, Q. Pei and T. S. C. Zetterstr?m]
  • Effect of different 5-HT1A receptor antagonists in combination with paroxetine on expression of the immediate–early gene Arc in rat brain - [R. Tordera, Q. Pei, M. Newson, K. Gray, M. Sprakes and T. Sharp]
  • The bioequivalence and therapeutic efficacy of generic versus brand-name psychoative drugs - [Giuseppe Borgheini]
  • Synthesis of the major metabolites of Paroxetine - [Mireia Segura, Lidia Roura, Rafael de la Torre and Jesús Joglar]
  • Enzymatic alkoxycarbonylation reactions on the intermediate in the synthesis of (?)-paroxetine, trans-N-benzyloxycarbonyl-4-(4′-fluorophenyl)-3-hydroxymethylpiperidine - [Gonzalo de Gonzalo, Rosario Brieva, Víctor M. Sánchez, Miguel Bayod and Vicente Gotor]
  • A reported case involving impaired driving following self-administration of xylazine - [Matthew E. Stillwell]
  • Troubles dysphoriques prémenstruels : diagnostic et traitements médicamenteuxPremenstrual dysphoric disorder: diagnostic and pharmacological treatment - [G. Benjelloun and A. Pelissolo]
  • The biological treatment of dangerous sexual offenders: A review and preliminary report of the Oregon pilot depo-Provera program - [Barry M. Maletzky and Gary Field]
  • Enantioselective synthesis of 3-substituted-4-aryl piperidines useful for the preparation of paroxetine - [K. S. Keshava Murthy, Allan W. Rey and Michael Tjepkema]
  • Dopamine depletion abolishes apomorphine- and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: a microdialysis study - [A. Balcioglu, K. Zhang and F. I. Tarazi]
  • Selective serotonin reuptake inhibitors combined with venlafaxine in depressed patients who had partial response to venlafaxine: four cases - [Ali Saffet Gonul, Fisun Akdeniz, Ozlem Donat and Simavi Vahip]
  • Determination of paroxetine in geriatric depression by high-performance liquid chromatography - [Isis A. Zainaghi, Vera L. Lanchote and Regina H. C. Queiroz]
  • Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze - [Venessa Beijamini and Roberto Andreatini]
  • Pindolol and the acceleration of the antidepressant response - [Per Plenge and Erling T. Mellerup]
  • Antidepressant-like effects in various mice strains in the tail suspension test - [Nadège Ripoll, Denis Joseph Paul David, Eric Dailly, Martine Hasco?t and Michel Bourin]
  • Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring - [Christine Frahnert, Marie Luise Rao and Katja Grasm?der]
  • Short- and long-term effects of MDMA (“ecstasy”) on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo - [Inger Lise Bogen, Kristin Huse Haug, Oddvar Myhre and Frode Fonnum]
  • Serotonin transporter and MAO-B levels in monoamine nuclei of the human brainstem are normal in major depression - [Violetta Klimek, Gary Roberson, Craig A. Stockmeier and Gregory A. Ordway]
  • Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus - [Glenn W. Kaatz, Varsha V. Moudgal, Susan M. Seo, John Bondo Hansen and Jette E. Kristiansen]


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 [23] 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
    41 42 43 44 45 46 47 48 49 50